Neurobiological effects of the green tea constituent theanine and its potential role in the treatment of psychiatric and neurodegenerative disorders

Nutritional Neuroscience

Volumn 17, Issue 4, 2014, Pages 145-155

  Lardner, Anne L ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Alpha wave; Alzheimers; Anti Psychotic; Anxiety; Central nervous system; Depression; Neuroprotection; Selective attention; Theanine

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 5 HYDROXYINDOLEACETIC ACID; AMYLOID BETA PROTEIN; BICUCULLINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CAFFEINE; CALCIUM; CASPASE 3; CORTICOSTERONE; DIZOCILPINE; DOPAMINE; GLUTAMIC ACID; GLYCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; METABOTROPIC RECEPTOR 1; MIC 801; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERVE GROWTH FACTOR; NEURONAL NITRIC OXIDE SYNTHASE; NEUROTROPHIN; SEROTONIN; STRESS ACTIVATED PROTEIN KINASE; THEANINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; GLUTAMIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT; PLANT EXTRACT; TEA;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BRAIN LEVEL; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEPRESSION; ELECTROENCEPHALOGRAPHY; HUMAN; LEARNING; LONG TERM POTENTIATION; MEMORY; MENTAL DISEASE; NEUROBIOLOGY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TEA; TOBACCO DEPENDENCE; ANIMAL; BLOOD BRAIN BARRIER; CHEMISTRY; COGNITION; DISEASE MODEL; DRUG EFFECTS; MENTAL DISORDERS; METABOLISM; NEURODEGENERATIVE DISEASES; SYNAPTIC TRANSMISSION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; DISEASE MODELS, ANIMAL; DOPAMINE; GLUTAMATES; HUMANS; LEARNING; LONG-TERM POTENTIATION; MEMORY; MENTAL DISORDERS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PLANT EXTRACTS; SEROTONIN; SYNAPTIC TRANSMISSION; TEA;

EID: 84901323138     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830513Y.0000000079     Document Type: Review

References (77)

1. Sakato Y. The chemical constituents of tea:111. A new amide theanine. Nippon Nogeikagaku Kaishi 1949;23:261-7.
2. Kai-Yang S, Chih-Li L, Syu KY, Lin CL, Hsiu-Chen H, Lin JK. Determination of theanine, GABA, and other amino acids in green, oolong, black, and pu-erh teas with dabsylation and high-performance liquid chromatography. J Agric Food Chem 2008;56:7637-43.
3. Unno T, Suzuki Y, Kakuda T, Hayakawa T, Tsuge H. Metabolism of theanine, gamma-glutamylethylamide, in rats. J Agric Food Chem 1999;47:1593-6.
4. Terashima T, Takido J, Yokogoshi H. Time-dependent changes of amino acids in the serum, liver, brain and urine of rats administered with theanine. Biosci Biotechnol Biochem 1999;63: 615-8.
5. Tsuge H, Sano S, Hayakawa T, Kakuda T, Unno T. Theanine, gamma-glutamylethylamide, is metabolized by renal phosphate-independent glutaminase. Biochim Biophys Acta 2003; 1620:47-53.
6. Yokogoshi H, Mochizuki M, Saitoh K. Theanine-induced reduction of brain serotonin concentration in rats. Biosc Biotechnol Biochem 1998;62:816-7.
7. Kimura R, Murata T. Influence of alkylamides of glutamic acid and related compounds on the central nervous system. 1. Central depressant effect of theanine. Chem Pharm Bull 1971;19: 1257-61.
8. Yamada T, Terashima T, Okubo T, Junega LR, Yokogoshi R. Effects of theanine-glutamyl ethylamide, on neurotransmitter release and its relationship with glutamic acid neurotransmission. Nutr Neurosci 2005;8:219-26.
9. Yadid G, Pacak K, Golomb E, Harvey-White DJ, Lieberman MD, Kopin JI, et al. Glycine stimulates striatal dopamine release in conscious rats. Br J Pharmacol 1993;110:50-3.
10. Kakuda T, Abe A, OguraM, Yoneda Y. Theanine, an ingredient of green tea, inhibits [3H]glutamine transport in neurons and astroglia in rat brain. J Neurosci Res 2008;86:1846-56.
11. Egashira N, Hayakawa K, Mishima K, Iwasaki K, Fijiwara M. Neuroprotective effect of gamma-glutamylethylamide (theanine) on cerebral infarction in mice. Neurosci Lett 2004;363:58-61.
12. Yamada T, Terashima T, Wada K, Ueda S, Ito M, Okubo T, et al. Theanine, γ-glutamylethylamide, increases neurotransmission concentrations and neurotrophin mRNA levels in the brain during lactation. Life Sci 2007;81:1247-55.
13. Ganguly K, Schinger FA, Wong TS, Poo MM. GABA itself promotes the developmental switch of neuronal GABAergic neurons from excitation to inhibition. Cell 2001;105:521-32.
14. Yokogoshi H, Kobayashi M, Mochizuki M, Terashima T. Effect of theanine, γ-glutamylethylamide, on brain monoamines and striatal dopaomine release in conscious rats. Neurochem Res 1998;23:667-73.
15. Wakabayashi C, Numakawa T, Ninomiya M, Chiba S, Kunugi H. Behavioural and molecular evidence for psychotropic effects in L-theanine. Psychopharmol 2012;219:1099-109.
16. Yokogoshi H, Mochizuki M, Saitoh K. Theanine-induced reduction of brain serotonin concentration in rats. Biosci Biotechonol Biochem 1998;62:816-7.
17. Yokogoshi H, Terashima T. Effect of theanine, γ-glutamylethylamide, on brain monoamines, striatal dopamine release and some kinds of behaviour in rats. Nutrition 2000;16:776-81.
18. Shen H, Shen X, Wang R, Wu M. Effects of theanine on cereberal ishaemia-reperfusion injury in rats (abstract only). Wei Sheng Yan Jiu 2011;40:684-7.
19. Schallier A, Vermoesen K, Loyens E, Liefferinge JV, Michotte Y, Smolders I, et al. L-theanine intake increases threshold for limbic seizures but decreases threshold for generalised seizures. Nutr Neurosci 2013;16:78-82.
20. Yamada T, Terashima T, Honma H, Nagata S, Okubo T, Juneja LR, et al. Effects of theanine, a unique amino acid in tea leaves, on memory in a rat behavioural test. Biosci Biotech Biochem 2008;72:1356-9.
21. Takeda A, Sakamoto K, Tamano H, Fukura K, Inui N, Suh SW, et al. Facilitated neurogenesis in the developing hippocampus after intake of theanine, an amino acid in tea-leaves, and object recognition memory. Cell Mol Neurobiol 2011;31: 1079-88.
22. Miodownik C, Maayan R, Ratner Y, Lerner V, Pintov L, Mar M, et al. Serum levels of brain-derived neurotrophic factor and cortisol to sulphate of dehydroiepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation therapy of antipsychotic therapy in schizophrenia and schizoaffectve disorder in patients. Clin Neuropharmac 2011;34:155-60.
23. Di X, Yan J, Zhao Y, Chang Y, Zhao B. L-theanine inhibits nicotine-induced dependence via regulation of the nicotine acetylcholine receptor-dopamine reward pathway. Sci China Life Sci. 2012;55:1064-74.
24. Cho HS, Kim S, Lee SY, Kim SJ, Chun HS. Protective effect of he green tea component L-theanine on environmental toxininduced neuronal cell death. Neurobiology 2008;29:656-62.
25. Gomez-Ramirez M, Kelly SP, Montesi JL, Fox JJ. The effect of L-theanine on alpha-band oscillatory brain activity during a visuo-spatial attention task. Brain Topogr 2009;22:44-51.
26. Walton HS, Dodd PR. Glutamate-glutamine cycling in Alzheimers disease. Neurochem Int 2007;50:1052-66.
27. Egashira N, Hayakawa K, Osajima M, Mishima K, Iwasaki K. Involvement of GABAA receptors in the neuroprotective effect of theanine on focal cerebral ischemia in mice. Pharmac Sci 2007;105:211-4.
28. Kakuda T. Neuroprotective effects of the green tea compounds theanine and catechins. Biol Pharm Bull 2002;25:1513-8.
29. Nagasawa K, Aoki H, Yasuda E, Nagai K, Shimohama S, Fugimoto S. Possible involvement of group 1 mGluRs in neuroprotective effects of theanine. Biochem Biophys Res Comm 2004;320:116-22.
30. Kakuda T, Nozawa A, Sugimoto A, Nino H. Inhibition by theanine of binding of [3H] AMPA, [3H] Kainate, and [3H] MDL 105 519 to glutamate receptors. Biosci Biotechnol Biochem 2002;66:2683-6.
31. Zukhurova M, Prosvirnina M, Daineko A, Simanenkova A, Petrishchev N, Sonin D, et al. L-theanine administration results in neuroprotection and prevents glutamate receptor agonist-mediated injury in the rat model of cerebral ishaemiareperfusion. Phytother Res 2012 (epub ahead of print).
32. Di X, Yan J, Zhao Y, Zhang J, Shi Z, Chang Y, et al. L-theanine protects the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamate-induced excitotoxicity via inhibition of the NMDA receptor pathway. Nueroscience 2010;168:778-86.
33. Nagasawa K, Aoki H, Yasuda E, Nagai K, Shimohama S, Fujimoto S. Possible involvement of group 1 mGLuRs in neuroprotective effect of theanine. Biochem Biophys Res Commun 2004;320:116-22.
34. Kim TI, Lee YK, Park SG, Choi IS, Ban JO, Park HK, et al. Ltheanine, an amino acid in green tea, attenuates β-amyloidinduced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-κB pathways. Free Rad Biol Med 2009;47:1601-10.
35. Kakuda T. Neuroprotective effects of theanine and its preventive effects on cognitive function. Pharm Res 2011;64:162-8.
36. Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, Ebihara S, et al. Green tea consumption and cognitive function: a cross-sectional study from the Tsurgaya project. Am J Clin Nutr 2006;83:355-61.
37. Kataoka Y, Utsunomiya K, Kimbara A, Fukushima K, Mori T, Shiba J. Preventative effect of green tea containing theanine at a high concentration on dementia in aged volunteers. J Jpn Mibyou Syst Assoc 2009;15:17-23.
38. Eschenauer G, Sweet BV. Pharmacology and therapeutic uses of theanine. Am J Health Syst Pharm 2006;63:26-30.
39. Kobayashi T, Nagato Y, Aon N, Juneja LR, Kim M, Yamamoto T, et al. Effects of L-theanine on the release of α-brain waves in human volunteers. Nippon Nogei Kagakukaishi 1998;72;153-7.
40. Song CH, Jung HJ, Oh SJ, Kim SK. Effects of theanine on the release of brain alpha wave in adult males. J Korean Nutr Soc (abstract only in English). 2003;36:918-23.
41. Gomez-Ramirez M, Higgins BA, Rycroft JA, Owen GN, Mahoney J, et al. The deployment of intersensory selective attention: a high-density electrical mapping study of the effects of theanine. Clin Neuropharmac 2007;30:25-38.
42. Owen GN, Parnell H, De Bruin EA, Rycroft JA. The combined effect of L-theanine and caffeine on cognitive performance and mood. Nutr Neuro 2008;11:93-8.
43. Nobre AC, Rao A, Owen GN. L-theanine, a natural constituent in tea, and its effect on mental state. Asia Pac J Clin Nutr 2008; 17(Supp 1):167-8.
44. Fox JJ, Morie KP, Laud PJ, Rowson MJ, de Bruin EA, Kelly SP. Assessing the effects of caffeine and theanine on the maintenance of vigilance on a sustained attention task. Neuropharmacol 2012;62:2319-26.
45. Kimura R, Murata T. Influence of alkylamides of glutamic acid and related compounds on the central nervous system. 1 V Effect of theanine on 3′, 5′-monophosphate formation in rat cerebral cortex. Chem Pharm Bulletin 1980;80:661-6
46. Kakuda T, Nozawa A, Unno T, Okamuaa N, Okai O. Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat. Biosci Biotech Biochem 2000;64:287-93.
47. Rogers PJ, Smith JE, Heatherley SV, Pleydell-Pearce CW. Time for tea: mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. Psychopharmacology 2008;195:569-77.
48. Kimura R, Kurita M, Murata T. Influence of glutamic acid and related compounds on the central nervous system. 111. Effect of theanine on spontaneous activity in mice. Yakugaku Zasshi 1975;95:892-5.
49. Sagesaka Y, Kakuda T, Kawamura K. Pharmacological effect of theanine. Proc of the Internat Symposium on Tea Science 1991; 7:362-5.
50. Jang HS, Jung JY, Jang IS, Jang KH, Kim SH, Hah JH, et al. Ltheanine partially counteracts caffeine-induced sleep disturbance in rats. Pharmac Biochem Behav 2012;101:217-21.
51. Owen GN, Parnell H, De Bruin WA, Rycroft JA. The combined effects of L-theanine and caffeine on cognitive performance and mood. Nutr Neurosci 2008;11:193-8.
52. Einother SJ, Martens VE, Rycroft JA, De Bruin EA. L-theanine and caffeine improve task switching but not intersensory attention or subjective alertness. Appetite 2010;54:406-9.
53. Abdou AM, Higashiguchi S, Horie K, Kim M, Hatta H, Yokogoshi H. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors 2006;26:201-8.
54. Yoto A, Murao S, Motoki M, Yokoyama Y, HorieN, Takeshima K, et al. Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks. Amino Acids 2012;43:1331-7.
55. Takeda A, Tamano H, Suzuki M, Sakamoto K, Oku N, Yokogoshi H. Unique Induction of CA1 LTP components after intake of theanine, an amino acid in tea leaves and its effect on stress response. Cell Mol Neurobiol 2012;32:41-8.
56. Yamin G. NMDA receptor-dependent signalling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus. J Neurosci Res 2009;87:1729-36.
57. Tian X, Sun L, Gou L, Ling X, Feng Y, Wang L, et al. Protective effect of L-theanine on chronic restraint stress-induced cognitive impairments in mice. Brain Res 2013;1503:24-32.
58. Lu K, Gray MA, Oliver C, Liley DT, Harrison BJ, Bartholomuesz CF, et al. The acute effects of L-theanine in comparison with alprezolam on anticipatory anxiety in humans. Hum Psychopharmacol 2004;19:457-65.
59. Kimura K, Ozeki M, Juneja LR, Ohira H. L-theanine reduces psychological and physiological stress responses. Biol Psychol 2007;74:39-45.
60. Hease T, Jenkinson J, Love C, Milam R, Perkins L, Adams C, et al. Anxiolytic effects of L-theanine-a component of green tea-when combined with midazolam, in the male Sprague-Dawley rat. AANA J 2009;77:445-9.
61. Ritsner MS, Miodownik C, Ratner Y, Schleifer T, Mar M, Pintov L, et al. L theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomised, double-blind, placebocontrolled, 2-center study. Clin Psych 2011;72:34-42.
62. Wise LE, Premaratne ID, Gamage TF, Lichtman AH, Hughes LD, Harris LS, et al. L-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like behaviour in mice. Pharm Bioch Behav 2012;103: 245-52.
63. Yin C, Liu Y, Yin X, Xhang L, Jia G, Zhuang X. Antidepressant-like effects of L-theanine in the forced-swim and tail suspension tests in mice. Phytother Res 2011;25:1636-9.
64. Dwivedi Y. Brain derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat 2009;5:4433-49.
65. Yoshiumura R, Ikenouchi-Sugita A, Hori H, Umene-Nakano W, Katsuki A, Havashi K, et al. (Abstract only) Brain derived neurotrophic factor (BDNF) and mood disorder. Nihon Shinkei Seishin Yakuriqaku Zasshi 2010;30:181-4.
66. Hashimoto K, Shimizu E, Ivo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004;45:104-14.
67. Dean B. The neurobiology of bipolar disorder: findings using human post-mortem central nervous system tissue. Aust NZ J Psychiatry 2004;38:135-40.
68. Brampilla P, Jerez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003;8:721-37.
69. Shiah IS, Yatham LN. GABA function in mood disorders; an update and critical review. Life Sci 1998;63:1289-303.
70. Cross DR, Kellerman G, McKenzie LB, Purvis KB, Hills GJ, Huisman H. A randomised targeted amino acid therapy with behaviourally at-risk adapted children. Child Care Health Dev 2011;37:671-8.
71. Lyon MR, Kapoor MP, Juneja LR. The effects of L-theanine (suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, doubleblind, placebo-controlled clinical trial. Altern Med Rev 2011; 16:348-54.
72. Mandel SA, Amit T, Kalafon L, Reznichenko L, Youdim M. Targetting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J. Nutr 2008;138: 1578-83S.
73. Weinreb O, Amit T, Mandel S, Youdim M. Neuroprotective molecular mechanisms of epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr 2009;4:283-96.
74. Moosemang S, Haider N, Klugbauer N, Adelsberger H, Langwieser N, Muller J, et al. Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J Neurosci 2005;25:9883-9.
75. Allen SJ, Watson JJ, Dawbarn D. The neurotrophins and their role in Alzheimer's disease. Curr Neuropharmacol 2011;9: 559-73.
76. Maina G, Rosso G, Zanardini R, Bogetto F, Genarrelli M, Bochio-Chiavetto L. Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: a case control study. J Affect Disord 2010;122:174-8.
77. Mercader JM, Fernández-Aranda F, Gratacòs M, Ribasés M, Badía A, Villarejo C, et al. Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients. Neuropsychobiology 2007; 56:185-90.